Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
The small leucine-rich proteoglycan (SLRP) family is widely expressed in extracellular matrix and aggravates tumor progression. However, epiphycan (EPYC), as a member of the SLRPs family, its biological function in cancer has not been confirmed. Thus, we aimed to clarify the role of EPYC in progress...
Guardado en:
Autores principales: | Lu Deng, Dandan Wang, Shouzhen Chen, Weiguo Hu, Ru Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/492ab741ed204abb8071ad37dc5804dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2
por: Xing,Feng, et al.
Publicado: (2018) -
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
por: Yi Ding, et al.
Publicado: (2021) -
MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2
por: Xie,Hui Hui, et al.
Publicado: (2019) -
Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer
por: Amber Gonda, et al.
Publicado: (2021) -
Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer
por: Lucía Pascual-Antón, et al.
Publicado: (2021)